“…This indicates that pathological changes in the transduction pathway between mucosal endocrine cells and primary afferent nerve terminals may lead to decreased motility and secretion in irritable bowel diseases. A number of studies by Percy and his colleagues Percy et al, 1992;Percy et al, 1993a;Percy et al, 1993b;Percy and Warren, 1994;Percy et al, 1997;Percy et al, 1998;Percy et al, 1999;Percy et al, 2001) have revealed that contractility of the muscularis mucosae closely linked with mucosal secretory function and its abnormal motility was concerned in inflammatory bowel diseases. As this physiological transduction mechanism, muscularis mucosae motor activity is translocated into mucosal secretion via the contraction-related PG synthesis and stimulation of non-cholinergic secretomotor neuron (Lawson and Powell, 1987;Percy et al, 2003).…”